Concepedia

Veronika Rayzman

VR

Statistics

Publications

5

Citations

526

H-Index

5

Active since

2005

Affiliations

CSL (United Kingdom)(Current)

CSL (Australia)

The University of Melbourne

Veronika Rayzman is an author at CSL (United Kingdom) specializing in immunology, antibody engineering, and monoclonal antibodies.

ORCID

Publications per year

2005–2016

5

Publications

5

A Factor XIIa Inhibitory Antibody Provides Thromboprotection in Extracorporeal Circulation Without Increasing Bleeding Risk

Magnus Larsson, Veronika Rayzman, Marc W. Nolte et al. · Science Translational Medicine · 2014 · 335 citations

, , +13

Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis

Ian K. Campbell, David Tai Leong, Kirsten M. Edwards et al. · The Journal of Immunology · 2016 · 84 citations

, , +17

Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR

Con Panousis, Veronika Rayzman, Terrance G. Johns et al. · British Journal of Cancer · 2005 · 47 citations · Full text

, , +17

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

Con Panousis, Urmi Dhagat, Kirsten M. Edwards et al. · mAbs · 2015 · 44 citations · Full text

, , +17

Development and Characterization of an Anti-FXIIa Monoclonal Antibody for the Treatment of Hereditary Angioedema

Zhihui Cao, Mark Biondo, Veronika Rayzman et al. · Journal of Allergy and Clinical Immunology · 2015 · 16 citations

, , +13

1–5 of 5